These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37290420)

  • 21. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
    Salerno M; Esposito V; Spinelli L; Di Somma C; Farina V; Muzzica S; de Horatio LT; Lombardi G; Colao A
    Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency.
    Colao A; Di Somma C; Spiezia S; Savastano S; Rota F; Savanelli MC; Lombardi G
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3416-24. PubMed ID: 18593773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study.
    Smith JC; Evans LM; Wilkinson I; Goodfellow J; Cockcroft JR; Scanlon MF; Davies JS
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):493-501. PubMed ID: 11966742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intima-media thickness in cardiovascularly asymptomatic hypopituitary adults with growth hormone deficiency: relation to body mass index, gender, and other cardiovascular risk factors.
    Leonsson M; Hulthe J; Oscarsson J; Johannsson G; Wendelhag I; Wikstrand J; Bengtsson BA
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):751-9. PubMed ID: 12460325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.
    Pfeifer M; Verhovec R; Zizek B; Prezelj J; Poredos P; Clayton RN
    J Clin Endocrinol Metab; 1999 Feb; 84(2):453-7. PubMed ID: 10022400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH; Kim YM; Lee GM; Yu J; Han HS; Yu J
    J Korean Med Sci; 2022 Mar; 37(11):e90. PubMed ID: 35315601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone.
    Saygılı S; Kocaağa M; Kaya G; Şükür M; Baş F; Poyrazoğlu Ş; Bundak R; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2023 Feb; 15(1):69-80. PubMed ID: 36416456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of left ventricular mass and function, lipid profile, and insulin resistance in Egyptian children with growth hormone deficiency: A single-center prospective case-control study.
    Metwalley KA; Farghaly HS; Abd El-Hafeez HA
    Indian J Endocrinol Metab; 2013 Sep; 17(5):876-82. PubMed ID: 24083170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency.
    Gómez JM; Sahún M; Vila R; Domènech P; Catalina P; Soler J; Badimón L
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):632-9. PubMed ID: 16712664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasculometabolic effects in patients with congenital growth hormone deficiency with and without GH replacement therapy during adulthood.
    Biscotto IP; Costa Hong VA; Batista RL; Mendonca BB; Arnhold IJP; Bortolotto LA; Carvalho LRS
    Pituitary; 2021 Apr; 24(2):216-228. PubMed ID: 33098037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults.
    Oliveira JL; Aguiar-Oliveira MH; D'Oliveira A; Pereira RM; Oliveira CR; Farias CT; Barreto-Filho JA; Anjos-Andrade FD; Marques-Santos C; Nascimento-Junior AC; Alves EO; Oliveira FT; Campos VC; Ximenes R; Blackford A; Parmigiani G; Salvatori R
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4664-70. PubMed ID: 17911170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity.
    Makimura H; Stanley T; Mun D; Chen C; Wei J; Connelly JM; Hemphill LC; Grinspoon SK
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5131-8. PubMed ID: 19837914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose homeostasis in GHD children during long-term replacement therapy: a case-control study.
    Capalbo D; Esposito A; Improda N; Wasniewska MG; Di Mase R; De Luca F; Bruzzese D; Salerno M
    Endocrine; 2018 Mar; 59(3):643-650. PubMed ID: 28875423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency.
    Ciresi A; Amato MC; Criscimanna A; Mattina A; Vetro C; Galluzzo A; D'Acquisto G; Giordano C
    Eur J Endocrinol; 2007 Mar; 156(3):353-60. PubMed ID: 17322495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency.
    Evans LM; Davies JS; Anderson RA; Ellis GR; Jackson SK; Lewis MJ; Frenneaux MP; Rees A; Scanlon MF
    Eur J Endocrinol; 2000 Mar; 142(3):254-62. PubMed ID: 10700719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of growth hormone therapy on metabolic parameters, adipokine and endothelial dysfunction in prepuberal children.
    Cañete MD; Valle-Martos R; Martos R; Cañete R; Valle M; Jiménez-Reina L
    Acta Paediatr; 2019 Nov; 108(11):2027-2033. PubMed ID: 31087421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
    Johannsson G; Albertsson-Wikland K; Bengtsson BA
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elderly people with hypothalamic-pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects.
    Li Voon Chong JS; Benbow S; Foy P; Wallymahmed ME; Wile D; MacFarlane IA
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):551-9. PubMed ID: 11106915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.